purpose study determine proton irradiation increase localization radiolabeled monoclonal antibodies mab subcutaneous sc intracranial ic human lung tumors xenotransplanted athymic rats rats carcinoembryonic antigen ncih441 tumors irradiated using NUMBER different proton regimens followed mab injected NUMBER hr dose irradiation animals euthanized NUMBER days later biodistribution assays proton irradiation NUMBER gray gy single dose NUMBER gy fractions given NUMBER consecutive days increased uptake sc tumors NUMBER NUMBER respectively compared nonirradiated controls enhancement radiolabeled mab delivery seen hemibrain irradiation animals ic tumors histopathological examination implantation sites showed viable poorly differentiated adenocarcinoma decrease blood vessel density decrease mitotic activity increase areas necrosis following irradiation compared adjacent nonirradiated tissue cea expression generally maintained vivo marker detectable tumor plasma cerebrospinal fluid oxygen radical production peripheral blood cells sc ic rats exhibited strikingly different patterns responsiveness ic injected animals NUMBER lighter sc injected counterparts neurological signs tumor progression noted results indicate proton irradiation used effectively increase delivery radiolabeled mab sc implanted human lung tumor xenografts order accomplish brain radiation schedules treatments needed cea expressing time dose 111in zce025 anti cea 111in zce025 tumor bearing time dose